0
May 1971, Vol 121, No. 5 >
Article | May 1971

Juvenile Papilloma of the Larynx FREE

James M. Oleske; Theodore Kushnick, MD
[+] Author Affiliations

Received for publication Dec 31, 1970.

Reprint requests to 100 Bergen St, Newark, NJ 07103 (Dr. Kushnick).


Am J Dis Child. 1971;121(5):417-419. doi:10.1001/archpedi.1971.02100160087011.
Text Size: A A A
Published online
Article
References
Comments

A two-year-old Negro-South American girl presented with juvenile laryngeal papilloma which necessitated an emergency tracheostomy. During the next 1½ years of hospitalization, she required general anesthesia for surgical excision of recurrent growths on an average of once every 3.7 weeks. Inasmuch as the process continued unabated, autogenous vaccine prepared from her tumor was administered by 15 weekly injections. There was an apparent dramatic beneficial response with vocalization around the tracheostomy tube occurring for the first time within two months of the start of vaccine therapy. Tumor growth regressed completely, the tracheostomy tube was removed within six months of the utilization of vaccine treatment and the patient was discharged after two years of hospitalization.

REFERENCES

1 +
Ferguson CF, Scott HW Jr:  Papilloma of larynx in childhood . New Eng J Med 230:477-482, 1944;.
2 +
Holinger PH, Shipkowitz NL, Holper JC, et al:  Studies of etiology of laryngeal papilloma and autogenous laryngeal papilloma vaccine . Acta Otolaryng 65:63-69, 1968;.
3 +
Newberg LJ, High HC, Lehman RH, et al:  Fatality from juvenile laryngeal papilloma . Arch Otolaryng 86:681-684, 1967;.
4 +
Majoros M, Parkhill EM, Devine KD:  Papilloma in the larynx in children . Amer J Surg 108:470-475, 1964;.
5 +
Holinger PH, Schild JA, Maurizi DG:  Laryngeal papilloma: Review of etiology and therapy . Laryngoscope 78:1462-1474, 1968;.
6 +
Shipkowitz NL, Holinger PH, Holper JG, et al:  Evaluation of autogenous laryngeal papilloma vaccine . Laryngoscope 77:1047-1053, 1967;.
7 +
Strome M:  Analysis of an autogenous vaccine in treatment of juvenile papilloma . Laryngoscope 79:272-279, 1969;.
8 +
Gross CW, Crocker TR:  Current management of juvenile laryngeal papillomata . Laryngoscope 80:523-543, 1970;.
9 +
Hellstrom KE, Hellstrom I:  Cellular immunity against tumor antigen . Advances Cancer Res 12:167-223, 1969;.
10 +
Jehn UW, Nathanson L, Schwartz RS, et al:  Lymphocyte stimulation by soluble antigen from malignant melanoma . New Eng J Med 283:329-333, 1970;.
11 +
Cooper HL:  Lymphocyte stimulation in malignant melanoma . New Eng J Med 283:369-370, 1970;.

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

1 +
Ferguson CF, Scott HW Jr:  Papilloma of larynx in childhood . New Eng J Med 230:477-482, 1944;.
2 +
Holinger PH, Shipkowitz NL, Holper JC, et al:  Studies of etiology of laryngeal papilloma and autogenous laryngeal papilloma vaccine . Acta Otolaryng 65:63-69, 1968;.
3 +
Newberg LJ, High HC, Lehman RH, et al:  Fatality from juvenile laryngeal papilloma . Arch Otolaryng 86:681-684, 1967;.
4 +
Majoros M, Parkhill EM, Devine KD:  Papilloma in the larynx in children . Amer J Surg 108:470-475, 1964;.
5 +
Holinger PH, Schild JA, Maurizi DG:  Laryngeal papilloma: Review of etiology and therapy . Laryngoscope 78:1462-1474, 1968;.
6 +
Shipkowitz NL, Holinger PH, Holper JG, et al:  Evaluation of autogenous laryngeal papilloma vaccine . Laryngoscope 77:1047-1053, 1967;.
7 +
Strome M:  Analysis of an autogenous vaccine in treatment of juvenile papilloma . Laryngoscope 79:272-279, 1969;.
8 +
Gross CW, Crocker TR:  Current management of juvenile laryngeal papillomata . Laryngoscope 80:523-543, 1970;.
9 +
Hellstrom KE, Hellstrom I:  Cellular immunity against tumor antigen . Advances Cancer Res 12:167-223, 1969;.
10 +
Jehn UW, Nathanson L, Schwartz RS, et al:  Lymphocyte stimulation by soluble antigen from malignant melanoma . New Eng J Med 283:329-333, 1970;.
11 +
Cooper HL:  Lymphocyte stimulation in malignant melanoma . New Eng J Med 283:369-370, 1970;.

Correspondence

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems